[Current problems in the treatment of diabetes mellitus with biguanides (review of the literature and personal data)].
Limanskaia
G F
GF
Shcherbak
A V
AV
Obrosova
I G
IG
Lesovaia
E S
ES
D000818:Animals; D001645:Biguanides / Q000627:therapeutic use*; D003921:Diabetes Mellitus, Experimental / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism; D016883:Diabetic Ketoacidosis / Q000517:prevention & control; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D007773:Lactates / Q000378:metabolism; D019344:Lactic Acid; D009243:NAD / Q000378:metabolism; D009249:NADP / Q000378:metabolism; D010084:Oxidation-Reduction / Q000187:drug effects; D051381:Rats; D013311:Streptozocin / Q000009:adverse effects
D001645:Biguanides; D007773:Lactates; D009243:NAD; D019344:Lactic Acid; D009249:NADP; D013311:Streptozocin; D007770:L-Lactate Dehydrogenase
Sovremennye problemy lecheniia sakharnogo diabeta biguanidami (obzor literatury i sobstvennye dannye).